Related Experiment Video
Updated: Feb 10, 2026
08:10
A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb BCG lux/M.Tb lux
Published on: September 14, 2011
14.2K
[BCG therapy in NMIBC: How much and for how long?.]
Andrea Sánchez Vázquez1, José Gregorio Pereira Arias1, Mikel Gamarra Quintanilla1
1Urología Clínica Bilbao. Clínica IMQ Zorrotzaurre. Bilbao. Bizkaia. España.
Archivos Espanoles De Urologia
|May 11, 2018
Summary
Bladder cancer recurrence after BCG treatment requires further therapeutic options. This review explores alternative treatments for non-muscle invasive bladder cancer (NMIBC) that progresses despite Bacillus Calmette-Guérin therapy.
Area of Science:
- Uro-oncology
- Cancer research
- Oncological treatments
Background:
- Bladder cancer is a global health concern, with non-muscle invasive bladder cancer (NMIBC) accounting for over 75% of cases.
- Bacillus Calmette-Guérin (BCG) instillations are standard treatment for high- and intermediate-risk NMIBC to prevent recurrence and progression.
- Despite BCG treatment, some patients experience disease recurrence or progression to muscle-invasive bladder cancer (MIBC).
Purpose of the Study:
- To review and summarize therapeutic strategies for managing bladder cancer recurrence following failed BCG treatment.
- To provide an overview of alternative treatment options for patients with NMIBC refractory to BCG therapy.
Main Methods:
- Literature review of existing studies and clinical trials.
- Analysis of therapeutic options for recurrent NMIBC after BCG failure.
- Synthesis of data on treatment efficacy and outcomes.
Main Results:
- Identified various treatment modalities for BCG-refractory NMIBC.
- Discussed the efficacy and limitations of different therapeutic approaches.
- Highlighted the challenges in achieving complete disease control in such cases.
Conclusions:
- Recurrence of bladder cancer after BCG treatment necessitates exploration of alternative therapies.
- A range of treatment options exist, but patient selection and treatment strategy are crucial for optimal outcomes.
- Further research is needed to optimize treatment protocols for BCG-unresponsive NMIBC.
More Related Videos
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
11.1K
10:11Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System
Published on: January 31, 2018
9.8K
Related Concept Videos
00:59Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
01:26Group Therapy
459
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
459
01:22Behavior Therapy
732
Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
732
01:28Drug Therapy
304
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
304
01:25Cognitive Therapy
1.1K
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
1.1K
01:30Electroconvulsive Therapy
1.2K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.2K